SECONDARY HYPERPARATHYROIDISM
Clinical trials for SECONDARY HYPERPARATHYROIDISM explained in plain language.
Never miss a new study
Get alerted when new SECONDARY HYPERPARATHYROIDISM trials appear
Sign up with your email to follow new studies for SECONDARY HYPERPARATHYROIDISM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Dialysis drug showdown: which vitamin d works best?
Disease control Not yet recruitingThis study compares two vitamin D medications—doxercalciferol (given through a vein) and calcitriol (taken by mouth)—to see which is better at lowering parathyroid hormone levels in kidney dialysis patients. About 98 adults on dialysis with high parathyroid hormone will take part…
Matched conditions: SECONDARY HYPERPARATHYROIDISM
Phase: NA • Sponsor: Chittagong Medical College • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New hope for kids with kidney disease: experimental vitamin d pill enters trial
Disease control Not yet recruitingThis study tests an extended-release vitamin D capsule (CTAP101) in 40 children aged 8 to 17 with stage 3 or 4 chronic kidney disease, secondary hyperparathyroidism, and low vitamin D. Participants take one capsule daily at bedtime for 8 weeks. The goal is to see how the body pro…
Matched conditions: SECONDARY HYPERPARATHYROIDISM
Phase: PHASE2 • Sponsor: OPKO Health, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC